News UK trial will see if data trumps hype over ivermectin's role... Despite limited data, anti-parasitic drug ivermectin has become widely used in some areas of the world as a treatment for COVID-19.
News BMS eyes filings for idiopathic pulmonary fibrosis drug Bristol Myers Squibb has reported phase 3 results with a new drug for idiopathic pulmonary fibrosis that could open the door to regulatory filings.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.